CA-VELODYNE-LIDAR,-INC.
19.6.2020 14:02:04 CEST | Business Wire | Press release
Rajant Corporation , the provider of Kinetic Mesh® wireless networks, and Velodyne Lidar, Inc. , a market leader in lidar technology, together are playing a vital role behind the agreement between DP World, UAE Region and the autonomous vehicle, robotics, and artificial intelligence (AI) specialist DGWorld. The contract will equip DP World’s Jebel Ali Port, the world’s ninth busiest seaport, with a fleet of DGWorld’s Autonomous Internal Terminal Vehicles (AITVs), including integration into the existing operational processes and infrastructures. This deployment supports DP World’s visionary strategy for future-proofed, seaport digitalization setting a new global standard for port operations, supply chains, and trade.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200619005029/en/
Rajant’s fully mobile M2M Kinetic Mesh BreadCrumb® wireless nodes, along with Velodyne’s Puck™ 3D lidar sensors, are vital to enable DGWorld to deliver and integrate their autonomous technology into the existing ITV fleet in multiple phases. DGWorld’s goal is to further increase the operational efficiency of the terminal and reduce the overall size of the currently used fleet.
Velodyne Puck sensors will provide rich computer perception data to help determine the safest way to navigate and direct AITVs in the complex, busy DP World, UAE Region seaport. The Rajant wireless mesh network provides a continuous communications infrastructure to ensure the AITVs are always interconnected and working together.
According to Matthias Krause, General Manager at DGWorld, “We trialed other wireless technologies, including the latest 5G, before discovering Rajant. They all had the same physical limitation, which is that wireless cannot go through large, metal container stacks. Rajant‘s Kinetic Mesh M2M technology allows the vehicles to talk to each other, which is critical to communicate fleet directions between container stacks. Velodyne Lidar has proven that their sensors are delivering unmatched data and can handle even harsh environments without problems, so it was an obvious choice. Both Velodyne and Rajant provided local support to ensure the project was a success. We have been impressed with their professionalism and extra support over the last several years.”
“Velodyne is honored to be selected to help fully automate terminal vehicle transport at Jebel Ali Port, the premier port in the Middle East. This exciting initiative will enable port terminal vehicles to work fully autonomously without drivers in a hectic, crowded environment,” said Erich Smidt, Executive Director Europe, Velodyne Lidar. “We want to thank our valued partner DGWorld for their vision in how Velodyne’s 3D lidar sensors can power automated guided vehicles (AGVs) that provide a quantum leap in port terminal automation in the region and beyond.”
“Selecting Rajant Kinetic Mesh to serve as the backbone for DGWorld and DP World Jebel Ali Port really highlights the difference between Rajant M2M InstaMesh technology and Wi-Fi, 4G, and 5G,” said Geoff Smith, Rajant’s Executive Vice President of Sales and Marketing. “We are pleased to be chosen to make this AITV fleet deployment possible. Rajant is the only industrial wireless network for mobile machine-to-machine (M2M) communication, which is also capable of overcoming RF signal blockages of large metal containers and signal interference from ships, radar, and neighboring ports.”
About Velodyne Lidar
Velodyne provides smart, powerful lidar solutions for autonomy and driver assistance. Headquartered in San Jose, Calif., Velodyne is known worldwide for its portfolio of breakthrough lidar sensor technologies. Velodyne’s founder, David Hall, invented real-time surround view lidar systems in 2005 as part of Velodyne Acoustics. Mr. Hall’s invention revolutionized perception and autonomy for automotive, new mobility, mapping, robotics and security. Velodyne’s high-performance product line includes a broad range of sensing solutions, including the cost-effective Puck™, the versatile Ultra Puck™, the autonomy-advancing Alpha Puck™, the ADAS-optimized Velarray™ and the groundbreaking software for driver assistance, Vella™.
About Rajant Corporation
Rajant Corporation is the exclusive provider of private wireless networks powered by the patented Kinetic Mesh® network, BreadCrumb® wireless nodes, and InstaMesh® networking software. With Rajant, customers can rapidly deploy a highly adaptable and scalable network that leverages the power of real-time data to deliver on-demand, mission-critical business intelligence. A low-latency, high-throughput, and secure solution for a variety of data, voice, video, and autonomous applications, Rajant’s Kinetic Mesh networks provide industrial customers with full mobility, allowing them to take their private network applications and data anywhere. With successful deployments in more than 55 countries for customers in military, mining, ports, rail, oil & gas, petrochemical plants, municipalities, and agriculture. Rajant is headquartered in Malvern, Pennsylvania with additional facilities and offices in Arizona, Kentucky, and Alabama. For more information, visit Rajant.com or follow Rajant on LinkedIn and Twitter.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200619005029/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Westinghouse Celebrates Record-breaking 80 Years of Nuclear Fuel Manufacture at Springfields30.3.2026 14:00:00 CEST | Press release
Fuel manufactured at Springfields has generated enough energy to supply the UK’s electricity demand for 26 years, avoiding the emission of nearly 3 billion tonnes of CO2 The Westinghouse Springfields facility in Lancashire, UK, has marked a significant milestone as the oldest continuous nuclear fuel manufacturing site in the world, starting from its original license on the 28th, March 1946. The site was chosen by the UK Government to develop nuclear fuel for the world’s earliest civil nuclear power stations, as well as subsequent Magnox and Advanced Gas Reactors (AGR) reactors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330135973/en/ From left to right: Sophie Lemaire; Marc Chevrel; Rory O'Neill; Craig Boothby; and Robert Gofton, CEO at Nuclear Institute Across the last eight decades, the Springfields site has supported the UK nuclear fleet, manufacturing more than eight million AGR pins, sintering and pressing over 5
HistoSonics Treats First Patients Evaluating the Edison® Histotripsy System for the Treatment of Benign Prostatic Hyperplasia (BPH)30.3.2026 14:00:00 CEST | Press release
HistoSonics, the developer of the Edison® Histotripsy System and novel histotripsy therapy platform, today announced the successful treatments of the first patients in WOLVERINE, a prospective feasibility trial evaluating the Edison® Histotripsy System for the treatment of benign prostatic hyperplasia (BPH) at Prince of Wales Hospital in Hong Kong, a teaching hospital for The Chinese University of Hong Kong. The Edison System is a novel, non-invasive, image guided platform that uses the mechanical properties of focused ultrasound, called histotripsy, to destroy unwanted tissue without the need for invasive procedures, and with potentially fewer side effects than traditional, invasive therapies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330349844/en/ HistoSonics Non-Invasive Edison Histotripsy System. Image credit: HistoSonics WOLVERINE is a prospective, multi-center, single-arm feasibility trial designed to evaluate
Biocytogen Grants Taisho Pharmaceutical a License to its RenNano® Fully Human Heavy Chain-Only Antibody Discovery Platform30.3.2026 13:00:00 CEST | Press release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that it has entered into a platform license agreement with Taisho Pharmaceutical Co., Ltd. (“Taisho”), granting Taisho the right to access and use Biocytogen’s proprietary RenNano® fully human heavy chain-only antibody (HCAbs) discovery platform for its internal research and development programs. Under the terms of the agreement, Taisho will leverage RenNano® mice to enable the generation and screening of fully human HCAbs in vivo and to support downstream research associated with antibody discovery. Financial terms of the agreement have not been disclosed. “We are very pleased to enter into this collaboration with Taisho,” said Dr. Yuelei Shen, President and CEO of Biocytogen. “RenNano® is a robust and powerful fully human VHH discovery platform that pro
Meiji Seika Pharma Invests in Centivax to Develop Next Generation Universal Vaccine Platform30.3.2026 13:00:00 CEST | Press release
Meiji Seika Pharma Co., Ltd. (Head Office: Chuo-ku, Tokyo, President and Representative Director: Toshiaki Nagasato) today announced a strategic investment in Centivax, Inc. (Head Office: South San Francisco, CA, USA), a biotechnology company developing next-generation vaccines and therapies for universal protection against highly diverse targets. Centivax’s lead program includes a universal seasonal influenza vaccine (Centi-Flu 01) currently in a Phase 1 clinical study. Unlike conventional seasonal flu vaccines, which must be manufactured annually based on recommended candidate vaccine viruses, Centivax’s platform focuses both antibody and cellular immune responses on conserved regions of the influenza virus that cannot mutate and are shared across strains and distant subtypes. This approach aims to generate broad, consistent, and durable immunity against both seasonal and pandemic influenza. Meiji’s strategic investment aims to accelerate the advancement of Centi-Flu 01 and further a
Samsung Biologics Strike: Labor Union Warns of CDMO Supply Chain Risks Following Overwhelming Vote30.3.2026 11:52:00 CEST | Press release
Union members overwhelmingly approve strike action with 95.52% voting in favor on a 95.38% turnout, clearing the final legal hurdle after mediation ceased.Union emphasizes this is a fight against structural corporate governance issues, citing unresolved allegations concerning unfair labor practices and ESG compliance risks.Management adhered to a group-level wage guideline rather than bargaining on the basis of Samsung Biologics' own performance, exposing a lack of independent bargaining authority. The Samsung Biologics Labor Union (President: Jaesung Park), representing approximately 75% of the company's total employees, announced today that its members have overwhelmingly voted in favor of a strike, with 95.52% voting in favor on a 95.38% turnout during a voting period from March 24 to March 29. Following the Incheon Regional Labor Relations Commission's decision to cease mediation, the union has now secured the legal mandate to strike. The union stressed that this strike is not mere
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
